One gene, SLC2A1, is present in five tumor entities (renal, urothelial, lung, liver and pancreatic cancer) and PLS3, SLC16a1, and SLC16A3 are present in four tumor entities (Table 4). This evidence concerns the gene PLS3 and pancreatic neoplasm.